Claim OwnershipThe Orange Pill Podcast
Subscribed: 2Played: 1
Subscribe
Copyright ©2025 KGK Science. All rights reserved.
Description
The Orange Pill Podcast 🎙️
Your go-to source for the latest in the dietary supplement and natural health product industry! Brought to you by KGK Science, a global leader in clinical research and regulatory consulting, this podcast delivers:
✔️ Breaking industry news and trends
✔️ Educational insights and practical takeaways
✔️ Discussions on cutting-edge research
✔️ Landmark cases and notable events shaping the field
Join us as we bridge the gap between science, regulation, and everyday impact.
Your go-to source for the latest in the dietary supplement and natural health product industry! Brought to you by KGK Science, a global leader in clinical research and regulatory consulting, this podcast delivers:
✔️ Breaking industry news and trends
✔️ Educational insights and practical takeaways
✔️ Discussions on cutting-edge research
✔️ Landmark cases and notable events shaping the field
Join us as we bridge the gap between science, regulation, and everyday impact.
61Â Episodes
Reverse
Most diets promise weight loss but leave you battling hunger, losing precious muscle, and facing rebound weight gain. But what if there’s another way?
In this episode of the Orange Pill Podcast, we break down a recent clinical trial published in Clinical Nutrition Open Science that tested the Bone Broth Diet (BBD), a mix of intermittent fasting, high-protein/low-carb meals, and collagen-rich bone broth.
Â
The results? Surprisingly powerful:
âś… Fat loss with muscle preservation
âś… Reduced hunger and cravings without sacrificing satisfaction
âś… Improved blood sugar, triglycerides, and waist circumference
âś… Built-in flexibility for long-term success
Â
This isn’t just another diet trend — it’s a new perspective on sustainable weight management.
From sourdough bread to kombucha, fermentation has long been a cornerstone of human diets. But what was once a preservation method is now driving some of the boldest innovations in food science. In this episode, we explore five surprising ways fermentation is transforming the future of food—from unlocking hidden nutrition and reintroducing microbial diversity, to turning food waste into gourmet ingredients, breeding microbes for flavor, and even creating animal products without the animal.
Fermentation has evolved from an ancient art into a modern marvel, one that promises healthier, more sustainable, and more exciting food for the future.
From farm to fork, our food supply chain is one of the most complex in the modern world. But while we often imagine technology’s role as simply faster machines or warehouse robots, the true disruption is happening in ways we don’t see.
In Episode 59 of the Orange Pill Podcast, we uncover four surprising ways AI and IoT are secretly reshaping the food industry—from collapsing product development timelines and predicting real consumer trends, to making food safety proactive and even delivering unexpected green dividends in logistics.
You’ll hear how these “invisible” systems are bringing clarity, foresight, and accountability to the food we eat, and why the biggest changes are still just over the horizon.
Caffeine is the world’s most widely consumed psychoactive substance, naturally found in coffee, tea, and chocolate, but now added to everything from energy drinks and supplements to waffles and chewing gum. With this rapid expansion, regulators and health experts are re-examining the science and safety of caffeine consumption.
In this episode, we break down:
Safe daily intake levels for healthy adults and vulnerable groups.
The unique risks for children, adolescents, and pregnant women.
How genetics can influence caffeine sensitivity and cardiovascular risk.
Emerging concerns with energy drinks, substance interactions, and long-term effects.
Where the science is strong—and where the biggest data gaps remain.
Coffee and caffeine are cultural cornerstones in the United States, but consumption trends have shifted dramatically over the past century. From the wartime rise of instant coffee to today’s specialty café culture and booming energy drink market, Americans’ relationship with caffeine keeps evolving.
In this episode of the Orange Pill Podcast, we unpack key findings from recent research on coffee and caffeine consumption patterns in the U.S.
Tune in as we break down the data, the history, and the health implications of America’s caffeine habits.
Â
In this episode of the Orange Pill Podcast, we explore the promise of D-mannose, a functional sugar gaining recognition as a non-antibiotic solution for urinary tract infections (UTIs).
We break down findings from a randomized, triple-blind, placebo-controlled study (Current Urology, 2025) where the product UClear, developed by KEB Nutraceuticals and clinically tested by KGK Science, demonstrated significant improvements in UTI symptoms after just 3 days of supplementation.
Join us as we unpack the science, the clinical trial data, and the broader implications for women’s health and nutraceutical innovation.
In Episode 55 of the Orange Pill Podcast, we dive into the newly released “Make Our Children Healthy Again Strategy” from the Make America Healthy Again (MAHA) Commission, chaired by U.S. Health and Human Services Secretary Robert F. Kennedy Jr.
This landmark strategy, unveiled on September 9, 2025, lays out more than 120 initiatives to combat the epidemic of chronic disease among America’s children. From restoring gold-standard science and reforming dietary guidelines to improving food labeling and expanding access to healthier options, the plan is designed to realign food and health systems for the next generation.
We’ll explore the strategy’s five core pillars:
Restoring rigorous science and research.
Executive actions to reform nutrition policies and labeling.
Streamlined access to healthier foods.
Education and public awareness initiatives.
Collaboration with the private sector to tackle root causes of disease.
Join us as we unpack how this sweeping vision could reshape the health landscape for families across the U.S. and what it means for the future of nutrition, wellness, and food policy.
Gen Z is reshaping the future of food. From sustainability and ethics to bold flavors, functional foods, and the powerful role of social media, their choices reflect values as much as taste and price. In this episode, we explore what drives Gen Z’s food preferences, the trends that matter most, and what brands need to know to stay relevant in a market increasingly defined by this generation. Whether you’re in product development, marketing, or food innovation, this episode is packed with insights into the consumers of tomorrow.
Statistics can make or break the credibility of a clinical trial, but too often they’re misunderstood. In this episode, we dive into the statistical backbone of clinical research — P-values, null hypothesis, sample size, effect size, and safety data — and uncover the common misconceptions that can distort how results are interpreted.
From the chronic confusion around what a P-value really means, to why sample size isn’t everything, to the difference between statistical significance and clinical relevance, we break it down in plain language for anyone working in dietary supplement and nutraceutical research.
Whether you’re a sponsor, regulator, or just passionate about evidence-based wellness, this episode will give you a clearer perspective on how to read between the numbers.
The women’s health supplement market is booming, projected to hit nearly $91 billion by 2033. But is this growth empowering women, or exploiting them? In this episode, we unpack the drivers behind the surge, from the self-care movement and influencer marketing to life-stage–specific formulas targeting PMS, fertility, and menopause.
We also dive into the risks of a largely unregulated market, the red flags consumers should watch for, and the critical role of third-party testing and professional guidance. With insights from health experts, we separate fact from fiction to help women make informed, evidence-based choices.
From gummies to personalized packs, discover how innovation, marketing, and regulation are shaping the future of women’s wellness, and what it means for you.
The protein wars are heating up, and one bar is leading the charge. In this episode, we unpack the “protein bar arms race” and the meteoric rise of the David Bar—a hyper-optimized, influencer-backed product redefining the category. From its extreme protein-to-calorie ratio and luxury branding to its aggressive supply chain play with Epogee, David is more than just a snack; it’s a symbol of the cultural obsession with protein and optimization.
We explore:
Why protein is now the undisputed king macronutrient.
How the David Bar’s marketing blitz turned influencers into pitchmen.
The role of fat substitute E.P.G. in reshaping product innovation.
The booming GLP-1 user demographic fueling protein demand.
Whether the protein craze is here to stay—or just another hype cycle.
Tune in as we dissect the science, strategy, and spectacle behind the “Scud missile of protein bars” and what it tells us about the future of food and wellness.
The FDA’s “Generally Recognized as Safe” (GRAS) rule was meant to keep food safe. But for decades, the self-GRAS loophole has allowed companies to introduce new additives without FDA review or public disclosure.
In this episode of the Orange Pill Podcast, we break down the unprecedented wave of reform efforts in 2025:
Executive action from HHS Secretary RFK Jr. and FDA Commissioner Marty Makary.
Congressional bills aiming to permanently close the loophole.
State-level legislation in New Jersey, Pennsylvania, and New York pushing transparency and bans.
The message is clear: the era of self-approved food additives is ending. Tune in as we unpack what this shift means for consumers, industry, and the future of food safety.
In this episode, we dive deep into the Make America Healthy Again (MAHA) Commission’s leaked strategy report, submitted to President Trump earlier this month and quietly leaked before its official release. The “Make Our Children Healthy Again Strategy” lays out sweeping changes to how the federal government addresses childhood chronic disease, from overhauling nutrition guidelines and banning food dyes, to tackling overmedicalization and rethinking the role of ultra-processed foods.
But the report isn’t without controversy. Critics point to missing depth on root causes like poverty and food insecurity, questionable transparency in its citations, and concerns about agricultural and pharma industry influence.
Join us as we break down:
The four drivers of childhood chronic disease identified by the Commission.
The most significant, and contentious, policy recommendations.
Why the report’s leak, delays, and past credibility issues are fueling political and public backlash.
The broader implications for public health, industry, and the future of U.S. nutrition policy.
This is more than a health policy debate, it’s about the future of America’s children and whether government intervention can truly move the needle.
The new EU-US trade deal is here, and it’s sending shockwaves through the dietary supplement industry. While it avoids the 30% tariff originally proposed, the agreement imposes a steep 15% tariff on about 70% of EU exports to the US, up from the previous 1.2%.
In this episode, we break down:
Who’s Hit Hardest: Why finished dietary supplements aren’t exempt, and what that means for European brands.
The Ingredient Exception: Which vitamins, minerals, amino acids, and other key nutrients escape the tariff.
The Confusion Factor: How conflicting political messages and non-binding terms create uncertainty for business planning.
Global Strategy Shifts: Why European supplement makers are eyeing Asia and Canada as alternative growth markets.
From tighter margins to delayed product launches, this is a pivotal moment for the industry, and we’re unpacking what it all means for competitiveness, market access, and long-term strategy.
In this episode, we unpack a major federal push to tackle the diet-related chronic disease crisis in America, with ultra-processed foods (UPFs) in the crosshairs. The U.S. Departments of Health and Human Services and Agriculture, working alongside the FDA and NIH, are launching coordinated initiatives to:
Define “ultra-processed foods” with a uniform federal standard.
Fund groundbreaking nutrition research through the new Nutrition Regulatory Science Program (NRSP).
Increase transparency in the food supply and address the root causes of chronic illness.
We explore what this means for public health, the food industry, and the future of nutrition policy in America. From the “Make America Healthy Again” vision to the implications for agriculture, regulation, and research, this is a pivotal moment in U.S. nutrition science.
In this episode of the Orange Pill Podcast, we dive into Health Secretary Robert F. Kennedy Jr.’s aggressive push to dismantle the GRAS (“Generally Recognized as Safe”) pathway — a move that’s shaking up both Big Food and the supplement industry.
We explore:
The origins and exploitation of the GRAS "loophole"
Why ultraprocessed foods are in the crosshairs
What this crackdown means for dietary supplements
Former FDA Commissioner David Kessler’s bold citizen petition
Whether this is a turning point in U.S. food safety policy
With bipartisan momentum and industry backlash mounting, is this the beginning of the end for self-certified food additives?
Â
The FDA is sounding the alarm. In a major regulatory move, the agency is recommending that 7-hydroxymitragynine (7-OH)—a potent synthetic derivative of kratom—be scheduled under the Controlled Substances Act. Why? Because this lab-created version of kratom’s active compound is up to 500% more potent than its natural form and is increasingly tied to severe health risks, including liver toxicity, seizures, substance use disorder, and even death.
In this episode, we break down:
 The FDA and DEA's joint stance on synthetic kratom
 The gray zone of regulation and enforcement
Public health concerns and the real-world impact of high-dose 7-OH products
The urgent need for research into kratom’s abuse potential and therapeutic value
As the debate around kratom heats up, this episode helps you stay informed on one of the most controversial substances in the supplement space.
This episode explores Canada’s evolving approach to CBD regulation, focusing on proposed changes that would allow low-dose cannabidiol products to be sold as Natural Health Products without a prescription. It covers the gaps in the current framework under the Cannabis Act, the results of public consultations, and Health Canada’s ongoing efforts to balance safety, access, and industry growth. The discussion also touches on implications for pharmacies, veterinary products, product labeling, and the broader impact on public health and the legal cannabis market.
Â
 Tune in now to stay ahead of the regulatory curve and understand what’s coming next for CBD in Canada.
Part One of Our Deep Dive into NHP Regulation Reform
Canada’s Natural Health Product (NHP) industry is facing its biggest regulatory shake-up in decades — and we’re here to break it all down. In this must-listen episode, we unpack the newly revised Product Licence Application (PLA) Class system and the controversial cost recovery program introduced by Health Canada.
From how Class I, II, and III applications work, to the major fee hikes and implementation timelines, we explore how these changes will impact supplement makers, small businesses, and your favourite products on the shelf. Tune in now, and don’t miss Part Two where we explore the next big frontier: CBD in NHPs.
This episode explores the surprising benefits of CarnoSyn® beta-alanine beyond sports. A new study reveals that a low, sustained-release dose improved cognitive function and reduced depression scores in older adults with below-average baseline scores—without side effects.
We break down the science behind brain carnosine, its link to BDNF and mood, and what this means for the healthy aging supplement market. Plus, a look at the regulatory pathway led by KGK Science and what’s next for SR CarnoSyn®.
CommentsÂ
Download from Google Play
Download from App Store
United States